ClinicalTrials.Veeva

Menu

Technology-assisted Language Intervention (TALI)

Cincinnati Children's Hospital Medical Center logo

Cincinnati Children's Hospital Medical Center

Status

Active, not recruiting

Conditions

Language Development
Hearing Loss, Bilateral

Treatments

Behavioral: Technology assisted language intervention
Behavioral: Treatment as usual

Study type

Interventional

Funder types

Other

Identifiers

NCT04857255
R01DC018550

Details and patient eligibility

About

This study is testing the effectiveness of augmentative and alternative communication technology among deaf or hard of hearing children for improving language development. Children will be randomized to receive either the technology intervention or treatment as usual

Enrollment

114 estimated patients

Sex

All

Ages

3 to 10 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 3-10 years
  • Documented permanent bilateral hearing loss with severity levels clinically defined moderate to profound).
  • Identified with a language deficit, defined by either the ratio of language standard scores to nonverbal intelligence quotient <.85 or a differences in nonverbal IQ and language standard scores of 10 points. Language scores may either be receptive or expressive.
  • Currently receiving speech-language therapy.

Exclusion criteria

Mild hearing loss and unilateral hearing loss

  • primary language other than English
  • significant motor impairments
  • nonverbal IQ <80
  • children with severe communication disorders (i.e. autism spectrum disorders).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

114 participants in 2 patient groups

Technology Assisted Language Intervention (TALI)
Active Comparator group
Description:
Augmentative and alternative communication software incorporated into active speech-language therapy
Treatment:
Behavioral: Technology assisted language intervention
Treatment as Usual
Active Comparator group
Description:
Speech language therapy child is typically receiving (no change to current care)
Treatment:
Behavioral: Treatment as usual

Trial documents
1

Trial contacts and locations

2

Loading...

Central trial contact

Jareen Meinzen-Derr, PhD; Laura Lane, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems